984
Participants
Start Date
December 31, 2007
Primary Completion Date
September 30, 2009
Study Completion Date
March 31, 2010
Azilsartan Medoxomil
Azilsartan Medoxomil 20 mg, tablets, orally, once daily for 2 weeks; titrated to 40 mg, tablets, orally, once daily for up to 22 weeks.
Azilsartan Medoxomil
Azilsartan Medoxomil 20 mg, tablets, orally, once daily for 2 weeks; titrated to 80 mg, tablets, orally, once daily for up to 22 weeks.
Valsartan
Valsartan 80 mg, tablets, orally, once daily for 2 weeks; titrated to 320 mg, tablets, orally, once daily for up to 22 weeks.
Huntsville
Glendale
Phoenix
Scottsdale
Tuscon
Beverly Hills
Burbank
La Jolla
Long Beach
Los Angeles
Paramount
San Diego
Santa Monica
Spring Valley
Tustin
Vista
Westlake Village
Ridgefield
Newark
Washington D.C.
DeLand
Fort Lauderdale
Hollywood
Inverness
Jacksonville
Boise
Chicago
Gurnee
Morton
Park Ridge
Avon
Bloomington
Crestview Hills
Baltimore
Columbia
Brockton
West Yarmouth
Ann Arbor
City of Saint Peters
Florissant
Kansas City
Washington
Wentzville
Charlotte
Salisbury
Shelby
Cincinnati
Delaware
Mogadore
Willoughby Hills
Zanesville
Oklahoma City
Eugene
Portland
Bridgeville
Downingtown
Jenkintown
Lansdale
Charleston
Spartanburg
Kingsport
Austin
Dallas
Fort Worth
Houston
Pearland
Rosenberg
San Antonio
Riverton
Salt Lake City
West Jordan
Arlington
Burke
Norfolk
Lakewood
Port Richard
Menomonee Falls
Santiago
Temuco
Cabo San Lucas
Colonia Escandón
Culiacán
Mexico City
Monterrey Nuevo Leon
Morelia
Querétaro
Chiclayo
Lima
Lead Sponsor
Takeda
INDUSTRY